TP53 and neoplasm: No significant association was found between somatic hypomethylation of this NotI site and patient gender, race, tumor location, MSI phenotype or the presence of mutations in TP53, KRAS or BRAF. We found, however, a positive association with patient age (P = 0.007, Student’s t-test, Table 1).